Alibaba’s stock has been on a volatile ride this year, leaving investors both hopeful and jittery. It rose 46.83% ...

Bessemer Group slashed its Etsy holdings by 95% in the first quarter, leaving just 1,489 shares worth $70,000. Other ...

Palantir is charging full throttle into AI-driven defense and government operations with two headline initiatives. The ...

Analysts have handed AbbVie a consensus “Moderate Buy” rating, reflecting cautious optimism about its future performance. Out ...

Mizuho hiked its price target for AMD from $135 to $152 and kept its “outperform” rating, fueling investor optimism. Several ...

A securities class action targets UnitedHealth over alleged fraud hurting investors from December 2024 to April 2025. Levi & ...

Lodestone Wealth Management trimmed its Home Depot stake by 14% in Q1, selling 708 shares, leaving 4,341 remaining. Several ...

Eli Lilly’s blockbuster GLP-1 drugs dominate headlines, but its broader portfolio deserves a standing ovation for driving ...

Merck shares dropped 1.7% Friday, trading below average volume, as analysts adjusted ratings and investors took profits. Wall ...

First Horizon Advisors increased its holdings in Johnson & Johnson by 5% in the first quarter, adding over 12,000 shares.

Oracle is doubling down on cloud and AI to secure its future in an increasingly competitive tech market. The company reported ...

Alta Advisers significantly increased its JPMorgan Chase stake by 55.8% in Q1, acquiring an additional 5,200 shares. The firm ...